BANGKOK: The Thai king’s sister has approved COVID-19 vaccine imports by an institution she sponsors, bypassing the government as it deals with surging infections and growing public anger over a slow and chaotic roll-out.
The secretary-general of the Chulabhorn Royal Academy wrote on Facebook that the “alternative vaccines” would supplement the government campaign until it could meet the country’s needs.
The government, which has long insisted it must handle all vaccine imports, will next month start its mass immunisation drive, which relies heavily on AstraZeneca vaccines manufactured locally by a company owned by the king.
The announcement in the official Royal Gazette took some in the military-backed government by surprise, and comes as Thailand suffers its most severe COVID-19 outbreak so far and growing unease about the vaccine plan.
READ: COVID-19: Provisional release on the cards for some inmates in Thailand amid overcrowding
The decree was announced late on Tuesday and expanded the Chulabhorn Royal Academy’s ability to respond to coronavirus. It was signed by Princess Chulabhorn, its chairwoman and the youngest sibling of King Maha Vajiralongkorn.
“The Royal Academy will procure ‘alternative vaccines’ until vaccines that are produced in the country reach a capacity that can sufficiently protect against outbreaks,” its secretary-general, Nithi Mahanonda, posted on Facebook, adding that it would comply with regulations on imports and registration.
READ: Vaccine hesitancy grows ahead of Thailand’s mass inoculation roll-out
Health Minister Anutin Charnvirakul said he was unaware of the royal order before it was published.
“I just saw the announcement last night,” Anutin said when asked about it during a local television interview.
“But if it is a benefit to the country, we are ready.”
Princess Chulabhorn Mahidol of Thailand pictured in 2011. (File photo: AFP/Gali Tibbon)
The Chulabhorn Royal Academy, which includes a hospital and research institute, has organised a news conference for Friday about what it said was its importation of the vaccine of Sinopharm. Thailand is expected to approve the Chinese vaccine for emergency use this week.
READ: Sinopharm’s two COVID-19 shots more than 70% effective, study says
It was not immediately clear how many vaccines the academy would import and when.
Thailand’s government is expecting to have available 6 million AstraZeneca doses and 3 million doses of the Sinovac vaccine next month, as it starts its main drive to inoculate 70 per cent of its more than 66 million people by year-end.
Other private hospitals plan to buy 10 million doses of Moderna vaccines through a state-run company.
Authorities on Thursday reported 47 new coronavirus deaths, a record for a second successive day, bringing total fatalities to 920, with 141,217 cases overall.
BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram